THE London Stock Exchange’s medical cannabis debutant MGC Pharmaceuticals has released is first quarterly update since listing showing record revenues of almost £500,000.
In the...
LONDON Stock Exchange-listed MGC Pharmaceuticals is to acquire Israeli clinical trial specialist MediCaNL for £3.3m (A$6m) in a share-based transaction.
On completion of the acquisition, MediCaNL...
FAST-GROWING UK CBD business Love Hemp has unveiled plans to list on the London Stock Exchange backed by an over-subscribed £5m fundraise.
Founded by schoolboy...
MEDICAL cannabis device maker Kanabo Group will today become the second cannabis company to list on the London Stock Exchange.
CEO Avihu Tamir believes it...
PERSISTENCE has paid-off for an Israeli businessman and a UK lawyer after the London Stock Exchange issued its first ever listing guidelines for cannabis...
PRESS RELEASE
FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...